Liver Disease Clinical Trials

Showing 381-400 of 1,279 trials

Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis

NCT03112681

prospective, multicenter, randomized, double-blind, placebo-controlled study to evaluate safety, tolerability and efficacy of saroglitazar magnesium 2 mg, 4 mg in Patients with Primary Biliary Cholangitis (PBC). A total 36 subjects will be enrolled in a ratio of 1:1:1 to receive either saroglitazar magnesium 2 mg or saroglitazar magnesium 4 mg or placebo.

Primary Biliary Cirrhosis

Zydus Therapeutics Inc.37 participantsStarted Aug 2017

Pasadena, California, United States • Miami, Florida, United States • Marietta, Georgia, United States +6 more locations

COMPLETED

Technical Validation of MR Biomarkers of Obesity-Associated NAFLD

NCT03674528

The overall goal of this collaborative research program is to develop, validate and translate advanced quantitative magnetic resonance (MR) biomarkers of obesity-associated non-alcoholic fatty liver disease (NAFLD). This protocol represents the research plan for two distinct phases. The first phase is an optimization phase. The second phase is designed to complete a rigorous test of conventional and advanced MRE techniques. Complementary anthropometric, laboratory, and MR measures will also be collected to characterize the cohort and identify factors that affect MRE performance

Non-Alcoholic Fatty Liver DiseaseNon-alcoholic Steatohepatitis

University of Wisconsin, Madison152 participantsStarted May 2018

La Jolla, California, United States • Madison, Wisconsin, United States

Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis

Technical Validation of MR Biomarkers of Obesity-Associated NAFLD

Related Searches

the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease.

Metabolic Syndrome and Fatty Liver Disease Among Egyptian Patients with Chronic HBV

Protocol for Muscle Attenuation Cut-offs in Cirrhosis

PK of NRL972 in Patients with Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD)

Effects of Tomato Consumption on Steatosis, Intestinal Function and Glucose and Lipid Metabolism in Subjects With NAFLD

Emulation of the Moderate Alcohol and Cardiovascular Health Trial (MACH15)

Monocytic Expression of HLA-DR After Liver Transplantation

Ultrasound and Attenuation Imaging

Safety and Efficacy of Fecal Microbiota Transplantation

Predictive Values of Presepsin Levels in ASciteS in Patients With Chronic Liver Failure

Study of Prevalence of Eating Disorder in Liver Transplant Patients

Efficacy of Conventional Dose Protocol vs Low Dose Protocol Albumin Use in Patients With Cirrhosis and High Risk Spontaneous Bacterial Peritonitis

MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin

bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma

Rotational Thromboelastometry [ROTEM] vs Thromboelastography [TEG] Guided Blood Component Use in Patients With Cirrhosis of Liver With Non-variceal Bleeding.

Building of Prognosis Model for Patients With Cirrhosis Based on Sarcopenia Assessed by Deep Learning

Study of Metabolic Dysfunction-Associated Steatotic Liver Disease Among Sohag University Employees

Ketogenic Diet in MASLD-related cACLD